ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07287
0,10%
Bitcoin
59.307,82
1,84%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) News

FEMY

Femasys (FEMY)

Femasys Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DatumZeitQuelleÜberschriftSymbolFirma
18/04/202414h30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
28/03/202421h05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
21/03/202414h00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
20/03/202413h15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
13/03/202414h00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
06/03/202415h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/03/202415h00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
28/02/202415h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
14/02/202403h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
14/02/202403h44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
06/02/202414h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
02/02/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/202422h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/202422h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
08/12/202315h28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
30/11/202323h17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
29/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
22/11/202322h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
22/11/202322h33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
22/11/202322h12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
21/11/202323h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
15/11/202323h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
15/11/202314h30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
02/11/202302h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/10/202314h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/10/202315h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/10/202315h27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
27/09/202314h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/09/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Kürzlich von Ihnen besucht

DBI
MDAX
MDAX
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
TG
RHM
Rheinmetall
NASDAQ
GOOGL
Alphabet
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
CBK
Commerzbank
CCOM
US500
US 500
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
FX
EURJPY
Euro vs Yen
TG
BAS
BASF
USOTC
DTEGY
Deutsche Telekom (QX)
TG
NOV
Novo Nordisk
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten